The KEMRI Graduate School was established by KEMRI Board of Management in 1992 to train postgraduate students in health research through opportunities presented by the well-established medical research facilities and global research expertise available at KEMRI.
The goal of the Graduate School is to develop a human resource base equipped with updated research skills and knowledge to provide solutions to the rapidly growing health care delivery challenges facing Kenya and the Africa region.
In 2003, The School entered into partnership with Jomo Kenyatta University of Agriculture and Technology (JKUAT) to offer Masters and PhD degrees in infectious diseases and tropical medicine. As of December, 2017, more than 400 Masters and 70 PhD students had graduated from the KEMRI-JKUAT collaboration.
In 2018, The Graduate School began the process with Kenya Commission of University Education (CUE) to obtain her own university charter as a specialized degree awarding arm of The Kenya Medical Research Institute.
A combination of academic, research, and training capacity available at KEMRI, makes postgraduate study at the KEMRI Graduate School (KGS) a fertile environment for young scientists aspiring to build a rewarding career in research.
In recognition of the need to build research capacity to address the rapidly growing health challenges in Kenya, the graduate school started in 2003 as collaboration with Jomo Kenyatta University of Agriculture and Technology (JKUAT) with the brand “Institute of Tropical Medicine and Infectious Diseases (ITROMID)”, and since evolved to become the KEMRI Graduate School (KGS).
Since 2003, KGS has contributed to local and international research capacity building in Master and Doctoral training in diverse areas such as public health, medical microbiology, virology and natural medicinal products research.
We offer a wide range of taught postgraduate degrees across three programme areas.The KEMRI Graduate School offers more than 20 Master of Science and Doctoral degree in Public Health, Biomedical Sciences and Medicinal Chemistry programmes.
|Public Health Programme||Biomedical Sciences Programme||Medicinal Chemistry Programme|
The KEMRI Graduate School accepts admission for both local and international students for all the programmes.
MINIMUM ADMISSION REQUIREMENTS
- Holders of a university degree with at least Upper-second Class Honors in the respective disciplines or equivalent qualifications
- Holders of a university degree with at least Lower-second Class Honors in the respective disciplines or equivalent qualifications plus acceptable evidence of research ability or academic work.
Application Procedure and Deadline
Candidates seeking admission are required to fill an [Application Form] and payment of a non-refundable application fees of Kshs. 1500.obtained from the office
Prof. Elijah Songok
Prof. Songok is a Virologist with more than 25 years’ experience in research and training on HIV/AIDS, Hepatitis and emerging viral infections.
He has won more than twenty international research grants and awards with more than fifty publications in peer reviewed journals.
Before his appointment to head KEMRI Graduate School, he has been a professor at The University of Manitoba in Canada and Kanazawa University in Japan. Prof. Songok brings a rich international experience in graduate research training to KEMRI.
Dr. Elizabeth Echoka
Dr. Echoka is a Public Health Researcher with more than 15 years experience in research and training in Maternal and Child Health and Health Systems Research.
Elizabeth holds a PhD and a Master’s degree, both in Public Health and a Bachelor’s Degree in Education.
Prof. Elizabeth Bukusi
I am enthusiastic about this grant opportunity to address the substantial public health gaps surrounding retention in HIV care and health outcomes among adolescents and young adults living with HIV in Kenya.
My primary research focuses on sexually transmitted infections; reproductive health; and HIV prevention, care, and treatment.
In 1995, we established the Research Care and Treatment Program at KEMRI. In addition to conducting research, the program aims to enhance local capacity to conduct socio-behavioral and biomedical research and provide HIV care through training and infrastructure development. In addition to my substantial experience conducting research in Kenya, providing HIV care, and mentoring and training different cadres of health care and research personnel, I have an interest in ethics and the development of systems and structures for regulating research in the institute and the country.
Prof. Rosemary Sang
Dr. Rosemary Sang is a researcher arbovirologist with background training in Medical Entomology and Medical Virology at MSc and PhD levels with over > 28 years experience in field and laboratory studies in arboviruses working at the Kenya Medical Research Institute (KEMRI)’s Center for Virus Research, the US Army medical research unit (USAMRU-K) in Kenya and long term collaboration with the International Center fo Insect Physilogy and Ecology’s Martin Luischer Emerging Infectious Diseases laboratory. She has led and mentored a strong arbovirus teams including MSc/PhD students, postdoctoral fellows and research teams in conducting extensive surveillance and ecological studies that have improved our knowledge and understanding of the ecology and epidemiology of arboviruses of public health importance in Kenya and the region.
Dr. Christine Bii
Dr. Christine Bii is interested in Medical Mycology and the significance of opportunistic fungal infections in HIV/AIDS, diabetes and cancer.
She has over 25 years of experience in research and training in fungal infections and established the only research and training Medical Mycology facility.
She coordinates the Medical Mycology course at the KEMRI-Graduate School and has supervised over 50 post graduate students.
Her current research focus is on; cryptococcal infections, Candida speciation, triazole resistance, dermatophytoses, mycotoxicoses, aspergillosis and opportunistic fungal infections in non-communicable diseases such as cancer and diabetes. She has published over 53 manuscripts in peer reviewed journals.
She has a number of active grants addressing fungal infections as emerging yet neglected significant pathogens.
Dr. Bernhards Ogutu
Dr Bernhards Ogutu is currently the Chief Research Officer with the Kenya Medical Research Institute (KEMRI) and Senior Clinical Trialist with the Malaria Clinical Trials Alliance of the INDEPTH-Network. Ogutu is also Director for the Centre for Research in Therapeutic Sciences (CREATES) at Strathmore University in Nairobi.
He has authored more than 150 peer reviewed publications. His areas of research expertise includes clinical trials, disease pathogenesis, and clinical therapeutics with a bias in malaria and clinical trials capacity development.
Dr Ogutu received his MBChB, MMed and PhD from the University of Nairobi. Dr Ogutu is a board certified Medical Practitioner, Paediatrician and Clinical Pharmacologist.
Dr. Doris Njomo
She is a member of the African Research Network for Neglected Tropical Diseases (ARNTD) and a mentor and supervisor of several Post Graduate Students.
She has received several grants including; WHO/TDR, Bill Gates Funding through the Neglected Tropical Diseases Support Centre (NTDSC), Atlanta, Georgia, UK DFID through the NTDSC to conduct Implementation and Operational
Research for Preventive Chemotherapy NTD Programmes: National Programme for Elimination of Lymphatic Filariasis; the National Programme for Schistosomiasis and Soil-Transmitted Helminthiasis Control and the National Programme for Elimination of Trachoma.
Dr. Evans Amukoye
He obtained his MB.ChB (1985) and M.Med (1992) from the University of Nairobi.
He has also undergone several professional training in Pediatrics’. He was a senior clinical fellow at the Institute of Child Health (London) in Critical Care, also had an attachment and training in Paediatric Brochoscopy/Respiratory from the University of Saporo, and Kyorin University(Japan) among others.
His Research interests includes MDR Tuberculosis, TB – infections, Pneumonia in Children, Influenza Virus, and HIV/AIDS.